Conformational impurity of disulfide proteins: Detection, quantification, and properties

Analytical Biochemistry

Volumn 342, Issue 1, 2005, Pages 78-85

  Chang, Jui Yoa ^a   Lu, Bao Yuan ^a   Li, Li ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Conformational impurity; Disulfide isomerization; Ribonuclease A; Scrambled isomers of EGF; Scrambled isomers of hirudin; Scrambled isomers of lactalbumin; Tick anticoagulant peptide

Indexed keywords

DRUG PRODUCTS; NEURODEGENERATIVE DISEASES; PHYSIOLOGY; PROTEINS; SULFUR COMPOUNDS; THERMODYNAMICS;

ANTICOAGULANT PEPTIDES; DISULFIDE ISOMERIZATION; RIBONUCLEASE A; SCRAMBLED ISOMERS OF EGF; SCRAMBLED ISOMERS OF HIRUDIN;

ISOMERS;

DISULFIDE; EPIDERMAL GROWTH FACTOR; HIRUDIN;

ARTICLE; CONCENTRATION RESPONSE; DEGENERATIVE DISEASE; EQUILIBRIUM CONSTANT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; THERMODYNAMICS;

ACARI;

EID: 20444406444     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2005.03.038     Document Type: Article

References (38)

1. C.B. Anfinsen Principles that govern the folding of protein chains Science 181 1973 223 230
2. F. Raschdorf, R. Dahinden, W. Maerki, W.J. Richter, and J.P. Merryweather Location of disulphide bonds in human insulin-like growth factors (IGFs) synthesized by recombinant DNA technology Biomed. Mass Spectrom. 16 1988 3 8
3. H. Meng, B.D. Burleigh, and G.M. Kelly Reduction studies on bacterial recombinant somatomedin C/insulin-like growth factor-1 J. Chromatogr. 443 1998 183 192
4. S. Hober, G. Forsberg, G. Palm, M. Hartmanis, and B. Nilsson Disulfide exchange folding of insulin-like growth factor I Biochemistry 31 1992 1749 1756
5. J.A. Miller, L.O. Narhi,, Q.X. Hua, R. Rosenfeld, T. Arakawa, M. Rohde, S. Prestrelski, S. Lauren, K.S. Stoney, L. Tsai, and M.A. Weiss Oxidative refolding of insulin-like growth factor I yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway Biochemistry 32 1993 5203 5213
6. J.-Y. Chang, F. Canals, P. Schindler, E. Querol, and F.X. Aviles The disulfide folding pathway of potato carboxypeptidase inhibitor J. Biol. Chem. 269 1994 22087 22094
7. J.-Y. Chang, L. Li, F. Canals, and F.X. Aviles The unfolding pathway and conformational stability of potato carboxypeptidase inhibitor J. Biol. Chem. 275 2000 14205 14211
8. K.A. Dill, and D. Shortle Denatured states of proteins Annu. Rev. Biochem. 60 1991 795 825
9. Y. Bai, J.S. Milne, L. Mayne, and S.W. Englander Protein stability parameters measured by hydrogen exchange Proteins 20 1994 4 14
10. M.M. Krishna, L. Hoang, Y. Lin, and S.W. Englander Hydrogen exchange methods to study protein folding Methods 34 2004 51 64
11. S.L. Mayo, and R.L. Baldwin Guanidinium chloride induction of partial unfolding in amide proton exchange in RNase A Science 262 1993 873 876
12. D.R. Shortle Structural analysis of non-native states of proteins by NMR methods Curr. Opin. Struct. Biol. 6 1996 24 30
13. J.-Y. Chang Denatured states of tick anticoagulant peptide: compositional analysis of unfolded scrambled isomers J. Biol. Chem. 274 1999 123 128
14. J.-Y. Chang, and L. Li The structure of denatured alpha-lactalbumin elucidated by the technique of disulfide scrambling: fractionation of conformational isomers of alpha-lactalbumin J. Biol. Chem. 276 2001 9705 9712
15. R.H. Williams, J.A. Maggiore, R.D. Reynolds, and C.M. Helgason Novel approach for the determination of the redox status of homocysteine and other aminothiols in plasma from healthy subjects and patients with ischemic stroke Clin. Chem. 47 2001 1031 1039
16. J.-Y. Chang The property of scrambled hirudins J. Biol. Chem. 270 1995 25661 25666
17. J.-Y. Chang, and L. Li The disulfide structure of denatured epidermal growth factor: preparation of scrambled disulfide isomers J. Protein Chem. 21 2002 203 213
18. J.-Y. Chang, P. Schindler, and B. Chatrenet The disulfide structures of scrambled hirudins J. Biol. Chem. 270 1995 11992 11997
19. J.-Y. Chang, A. Bulychev, and L. Li A stabilized molten globule protein FEBS Lett. 487 2000 298 300
20. L.C. Wu, and P.S. Kim A specific hydrophobic core in the alpha-lactalbumin molten globule J. Mol. Biol. 280 1998 175 182
21. L.C. Wu, Z.Y. Peng, and P.S. Kim Bipartite structure of the alpha-lactalbumin molten globule Nat. Struct. Biol. 2 1995 281 286
22. B.A. Schulman, C. Redfield, Z.Y. Peng, C.M. Dobson, and P.S. Kim Different subdomains are most protected from hydrogen exchange in the molten globule and native states of human alpha-lactalbumin J. Mol. Biol. 253 1995 651 657
23. J.-Y. Chang A two-stage mechanism for the reductive unfolding of disulfide containing proteins J. Biol. Chem. 272 1997 69 75
24. J.-Y. Chang, L. Li, and P.H. Lai A major kinetic trap for the oxidative folding of human epidermal growth factor J. Biol. Chem. 276 2001 4845 4852
25. E.Y. Chi, S. Krishnan, T.W. Randolph, and J.F. Carpenter Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation Pharm. Res. 9 2003 1325 1336
26. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
27. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C.M. Dobson, and M. Stefani Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
28. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 2004 S10 S17
29. M.P. Mattson, and M. Sherman Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation Neuromol. Med. 4 2003 109 132
30. M. Hashimoto, E. Rockenstein, L. Crews, and E. Masliah Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases Neuromol. Med. 4 2003 21 36
31. E.H. Koo, P.T. Lansbury Jr., and J.W. Kelly Amyloid diseases: abnormal protein aggregation in neurodegeneration Proc. Natl. Acad. Sci. USA 96 1999 9989 9990
32. A.L. Fink Protein aggregation: folding aggregates, inclusion bodies, and amyloid Fold Des. 3 1998 R9 R23
33. P.T. Lansbury Jr., and B. Caughey The chemistry of scrapie infection: implications of the "ice-9" metaphor Chem. Biol. 2 1995 1 5
34. F.E. Cohen, and S.B. Prusiner Pathologic conformations of prion proteins Annu. Rev. Biochem. 67 1998 793 819
35. M.C. Manning, K. Patel, and R.T. Borchardt Stability of protein pharmaceuticals Pharm. Res. 11 1989 903 918
36. R.L. Garnick, N.J. Solli, and P.A. Papa The role of quality control in biotechnology: an analytical perspective Anal. Chem. 60 1988 2546 2557
37. D.T. Liu Deamidation: a source of microheterogeneity in pharmaceutical proteins Trends Biotechnol. 10 1992 364 369
38. L.J. Janis, and G.C. Davis Analytical strategies for the determination of protein modifications Dev. Biol. Stand. 83 1994 135 142